Gene Yeo

Invests in

AI & Machine LearningBiotechDeep Tech

Investments

Per the firm's website.

Colleagues at Red Tree Venture

AS

Adam Silverman

Red Tree Venture Labs Biologics at Red Tree Venture

AL

Antonio Lepore

Senior Associate at Red Tree Venture

AO

Ariell Ortega

Executive Assistant at Red Tree Venture

BR

Bill Robinson

Scientific Advisory Board - Immunology; Chief, Stanford Division of Immunology and Rheumatology at Red Tree Venture

BS

Brian Stearns

Red Tree Venture Labs Chemistry at Red Tree Venture

CL

Cassie Lue

VP of Investor Relations at Red Tree Venture

CM

Crystal Mackall

Scientific Advisory Board - Oncology; Director, Stanford Center for Cancer Cell Therapy at Red Tree Venture

DN

Deborah Nguyen

Red Tree Venture Labs Operating Partner at Red Tree Venture

Frequently asked questions

Who is Gene Yeo?

Gene Yeo is the Sanford Stem Cell Institute Endowed Chair and Professor of Cellular and Molecular Medicine at UC San Diego, where he directs the Center for RNA Technologies and Therapeutics and the Sanford Stem Cell Institute's Innovation Center, and serves as Chief Scientist for Sanford Laboratories for Innovative Medicine. Trained as a computational biologist in machine learning during his PhD at MIT and in stem cell biology as a Crick-Jacobs fellow at the Salk Institute, his lab develops molecular and computational technologies to study RNA processing and RNA binding proteins in development and disease. He has founded several biotech companies and serves as a scientific advisor to Red Tree.

Where does Gene Yeo work?

Gene Yeo is Founding Member, UCSD Institute for Genomic Medicine (Scientific Advisory Board) at Red Tree Venture.

What does Gene Yeo invest in?

Gene Yeo invests in AI & Machine Learning, Biotech, Deep Tech.

What companies has Gene Yeo invested in?

Investments tracked here include AmberBio, Atomic.AI, Automera, EclipseBio, Insitro, Orbital Therapeutics, Proteona, Radar Therapeutics, Trotana.